Revised guideline on immunophenotyping in acute leukaemias and chronic lymphoproliferative disorders

Clinical and Laboratory Haematology

Volumn 24, Issue 1, 2002, Pages 1-13

  Bain, B J ^a   Barnett, D ^a   Linch, D ^a   Matutes, E ^a   Reilly, J T ^a  

^a British Society for Haematology   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; CELL NUCLEUS ANTIGEN; CYCLIN D1 MONOCLONAL ANTIBODY; EDETIC ACID; HEPARIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD117; MONOCLONAL ANTIBODY CD9A; MONOCLONAL ANTIBODY CD9B; TISSUE CULTURE MEDIUM; TRYPAN BLUE; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; TUMOR ANTIGEN;

ACUTE LEUKEMIA; ANTICOAGULATION; B LYMPHOCYTE; BLOOD SAMPLING; BONE MARROW; BURKITT LYMPHOMA; CELL STRUCTURE; CELL VIABILITY; CEREBROSPINAL FLUID EXAMINATION; CHROMOSOME ANALYSIS; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHATIC LEUKEMIA; LYMPHOPROLIFERATIVE DISEASE; MYELOID LEUKEMIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STEM CELL; T LYMPHOCYTE; TISSUE CULTURE; UNITED KINGDOM; ACUTE DISEASE; ARTICLE; BLOOD CELL; CHRONIC DISEASE; IMMUNOLOGY; INSTRUMENTATION; LABORATORY DIAGNOSIS; LEUKEMIA; METHODOLOGY; PATHOLOGY; STANDARD;

ACUTE DISEASE; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; BLOOD CELLS; BONE MARROW; CHRONIC DISEASE; HUMAN; IMMUNOPHENOTYPING; LEUKEMIA; LYMPHOPROLIFERATIVE DISORDERS; SPECIMEN HANDLING; HUMANS;

EID: 0036008654     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2257.2002.00135.x     Document Type: Review

References (61)

1. Differential expression of B29 (CD79b) and mb-1 (CD79a): Proteins in acute lymphoblastic leukaemia
2. High frequency of immunophenotype changes in acute myeloid leukemia at relapse: Implications for residual disease detection
3. For the General Haematology Task Force of the British Committee for Standards in Haematology. Guideline for the flow cytometric enumeration of CD34+ haemopoietic stem cells
4. Standardisation of lymphocyte antibody binding capacity (ABC). A muticentre study
5. Determination of leucocyte antibody binding capacity (ABC): The need for standardization
6. Human homologue of the rat chondroitin sulfate proteoglycan, NG2, detected by monoclonal antibody 7.1 identifies childhood acute lymphoblastic leukemias with t (4;11) (q21;q23) or t (11;19) (q23;p13) and MLL rearrangements
7. Proposals for the immunological classification of acute leukemias
8. The reliability and specificity of c-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias
9. The value of c-kit in the diagnosis of biphenotypic acute leukaemia
10. Quantitative analysis of leukocyte membrane antigen expression: Normal adult values
11. Involvement of the CCND1 gene in hairy cell leukemia
12. Immunophenotyping of acute leukaemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukaemic blasts in three colour analysis
13. US-Canadian consensus recommendations on the immunophenotypic analysis of haematologic neoplasia by flow cytometry
14. Acute leukaemias of ambiguous lineage
15. mb-1: A new marker for B-lineage lymphoblastic leukemia
16. The role of an anti-myeloperoxidase antibody in the diagnosis and classification of acute leukaemia. A comparison with light and electron microscopy cytochemistry
17. Quantitative analysis of CD79b, CD5 and CD19 in B-cell lymphoproliferative disorders
18. Alterations of Hle-1 (T200) fluorescence intensity on acute lymphoblastic leukaemia cells may relate to therapeutic outcome
19. Cytogenetic findings in acute biphenotypic leukemia
20. The c-kit proto-oncogene receptor is expressed on a subset of human CD3-, CD4-, CD8-(triple negative) thymocytes
21. Updated data on Vgene mutation status and CD38 expression in B-cell
22. IgV status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukaemia
23. Quantitation and valence of antibodies bound to cells
24. Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia
25. Cyclin D1 by flow cytometry as a useful tool in the diagnosis of B-cell malignancies
26. Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML)
27. Differential TdT expression in acute leukaemia by flow cytometry: A quantitative study
28. Quantitative flow cytometry can distinguish between normal and B-cell precursors
29. Immunophenotyping in the diagnosis of acute leukaemias
30. Immunophenotyping in the diagnosis of chronic lymphoproliferative disorders
31. Differential expression of CD3 and CD7 in T-cell malignancies: A quantitative study by flow cytometry
32. Flow cytometric detection of intracellular antigens for immunophenotyping of normal and malignant leukocytes. BTS technical report
33. Immunoglobin V genes and CD38 expression in CLL
34. Unmutated Ig V (H) genes are associated with a more aggressive form of chronic lymphocytic leukemia
35. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia
36. Quantitation of cellular expression of CD69 on activated T cells using R-phycoerythrin labelled beads
37. The standardization of quantitative direct immunofluorescence: The stabilized cellular immunofluorescent analysis (SCIFA)
38. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia - A study of 500 cases
39. Outcome of biphenotypic acute leukemia
40. Flow cytometry detection of CD79a expression in T-cell acute lymphoblastic leukemias
41. Quantification of CD24 and CD45 antigens in parallel allows a precise determination of B-cell maturation stages. Relevance for the study of B-cell neoplasms
42. Leukemia-associated changes identified by quantitative flow cytometry. I. CD10 expression
43. The immunophenotype of 177 adults with acute myeloid leukemia: Proposal of a prognostic score
44. Adult biphenotypic acute leukaemia: An entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein overexpression
45. High correlations of anti-CMV titers with lymphocyte activation and CD% & antibody-binding capacity as estimated with three-color, quantitative flow cytometry in blood donors
46. Expression of TIA-1 and TIA-2 in T-cell malignancies and T-cell lymphocytosis
47. Definition of acute biphenotypic leukemia
48. The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes
49. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL
50. NG2 expression in MLL rearranged acute myeloid leukaemia is restricted to monoblastic cases
51. Diagnostic approaches to acute promyelocytic leukaemia
52. The rapid diagnosis of acute promyelocytic leukemia using PML (5E10) monoclonal antibody
53. Coexpression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma
54. Detection of membrane and intracellular antigens by flow cytometry following ORTHO PermeaFix fixation
55. Quantification of cell-surface antigens by indirect immunofluorescence using monoclonal antibodies
56. Quantitative determination of antibody binding capacity (ABC) by flow cytometry
57. The human homologue of rat NG2, a chondroitin sulfate proteoglycan is not expressed on the cell surface of normal haemopoietic cells but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q23
58. dim T-lymphocytes increase with age: Evidence for a memory cytotoxic phenotype
59. Aberrations of the B-cell receptor B29 (CD79b) gene in chronic lymphocytic leukemia
60. Detection of acute leukemia cells with 11q23 rearrangements by flow cytometry: Sensitivity and specificity of monoclonal antibody 7.1
61. Expression of the immunoglobulin-associated protein B29 in B-cell disorders with the monoclonal antibody SN8 (CD79b)